echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Australia kicks 17 hot drugs out of state subsidies

    Australia kicks 17 hot drugs out of state subsidies

    • Last Update: 2015-11-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: global network November 5, 2015 according to the report of Australia's xinkuai.com on November 4, 17 popular drugs, including headache and constipation treatment, will no longer be prescription drugs since 2016, and it is estimated that the government will save 500 million Australian dollars (about 2.28 billion yuan) in five years According to reports, the Pharmaceutical Benefits Advisory Committee lists generic over-the-counter drugs that will no longer be exempt from fees as of January 1, 2016 Drugs to be delisted include paracetamol, aspirin, hydrocortisone and glycerin There were 876 prescriptions containing these drugs in 2014, which brought a cost of $87.3 million (about rmb399 million) to the pharmaceutical benefits scheme Australia's health minister, Susan Ley, said on the evening of Tuesday that the government would accept the advice of the drug Welfare Advisory Committee to correct abnormalities so that the government could change the direction of funding While those drugs account for only 15% of subsidized over-the-counter drugs under the drug benefit scheme, they contribute 87% of the cost of such drugs "There is no doubt that many of these over-the-counter drugs, such as paracetamol and aspirin, are simple and easy treatments for many conditions This is an anomaly in the system, which has over the years caused patients and taxpayers to unnecessarily spend more money to get prescriptions, and these drugs are usually available at cheaper prices in pharmacies or supermarkets " Susan Lee said the new measures could save the government 500 million yuan over the next five years Some patients may take longer to access the drug safety net, but she noted that competition helps to maintain low costs and that the drug Welfare Advisory Committee had recommended against changes to more expensive over-the-counter drugs for diseases such as asthma and allergies "Every dollar we use to subsidize the inefficiencies of drug benefit programs is the money we can use to get new drugs that may save lives on the list This is another case where we are bringing smart public policy It will balance the needs of patients, taxpayers and future investments in new drugs " The Australian government also announced the inclusion of iclusig, a therapeutic drug for chronic myeloid leukemia and acute lymphocytic leukemia, into the drug welfare plan, which could cost a $20 million (about 91.4 million yuan) over the next five years The drug can cost 66500 Australian dollars (about 304000 yuan) per year for patients, but with subsidies, only 6.1 Australian dollars and 37.7 Australian dollars are needed for preferential patients and ordinary patients each time The drug deal, which was approved by the Senate earlier this year, includes the option for pharmacists to co pay patients a $1 per prescription reduction.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.